Sector: N/A | Industry: N/A |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 500 W Monroe St Fl 28 CHICAGO IL 60661-3773 |
Tel: | 1-312-9066600 |
Website: | https://www.adtalem.com |
IR: | See website |
Key People | ||
Stephen W. Beard President, Chief Executive Officer, Director | Steven K. Tom Senior Vice President, Chief Customer Officer | Robert J. Phelan Chief Financial Officer, Senior Vice President |
Michael Betz President - Walden University | Karen Cox President - Chamberlain University | Scott Liles President - Adtalem Medical and Veterinary |
Cheryl James Senior Vice President, Chief Human Resource Officer | Maurice Herrera Senior Vice President, Chief Marketing Officer | Douglas G. Beck Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services | Blake Simpson Senior Vice President, Chief Communications Officer and Corporate Affairs Officer |
Business Overview |
Adtalem Global Education Inc. is a provider of professional talent to the healthcare industry. The Company operates through three segments: Chamberlain, Walden, and Medical and Veterinary. Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment includes the operations of Chamberlain University (Chamberlain). Walden segment offers more than 100 online certificate, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. Medical and Veterinary segment offers degree and non-degree programs in the medical and veterinary postsecondary education industry. This segment includes the operations of the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. |
Financial Overview |
For the nine months ended 31 March 2024, Adtalem Global Education Inc revenues increased 8% to $1.17B. Net income before extraordinary items increased 11% to $87.1M. Revenues reflect Chamberlain segment increase from $149.7M to $466.5M, Walden segment increase from $132.9M to $439M, Medical and Veterinary segment increase from $86.5M to $269.2M, United States segment increase from $282.6M to $905.5M, Barbados, Dominica, St Kitts and St. |
Employees: | 4,368 as of Jun 30, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $2,930M as of Mar 31, 2024 |
Annual revenue (TTM): | $1,539M as of Mar 31, 2024 |
EBITDA (TTM): | $299.60M as of Mar 31, 2024 |
Net annual income (TTM): | $110.66M as of Mar 31, 2024 |
Free cash flow (TTM): | $238.73M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $468.34M as of Mar 31, 2024 |
Shares outstanding: | 37,606,468 as of Apr 26, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |